Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Inflammopharmacology|August 3, 2023
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effectsMarco Di Battista, Laura Tavanti, Francesco Pistelli, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic SclerosisCosimo Bruni, Lavinia Mattolini, Lorenzo Tofani, et al.
La Radiologia Medica|March 13, 2019
Management of incidental pulmonary nodule in CT: a survey by the Italian College of Chest RadiologyCristiano Rampinelli, Giuseppe Cicchetti, Giancarlo Cortese, et al.
Joint Bone Spine|June 26, 2025
Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosisMarco Di Battista, Chiara Romei, Laura Tavanti, et al.
Rheumatology (Oxford, England)|October 26, 2021
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screeningLuna Gargani, Chiara Romei, Cosimo Bruni, et al.
European Radiology|March 1, 2023
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trialMario Mascalchi, Chiara Romei, Chiara Marzi, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3-24-Month Follow-Up and Correlation with Functional ParametersSalvatore Claudio Fanni, Federica Volpi, Leonardo Colligiani, et al.
ERJ Open Research|May 7, 2026
Artificial intelligence and radiomics in drug-induced interstitial lung diseaseGuido Marchi, Salvatore Claudio Fanni, Mattia Mercier, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be AddressedMario Mascalchi, Giulia Picozzi, Donella Puliti, et al.
Pageof 6